Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1941
-
1942
-
1943
-
1944
Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice.
Published 2008“…Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. H&E (left) and Azan (middle) staining show 5-week-old <i>Slc39a13</i>-KO cornea is thinner than wild-type littermates. …”
-
1945
AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production.
Published 2013“…Data are expressed as mean ± SD (n = 5 per group for A and B; n = 4 per group for C and D; *p<0.05 <i>vs.…”
-
1946
-
1947
-
1948
-
1949
-
1950
The decreased stationary phase density of strains lacking pSymB in bulk soil is due to carbon limitation and can be traced to two loci.
Published 2014“…<p>(<b>A</b> – top panel) The strain with a deletion of B116 (orange) shows a slight, but repeatable, decrease in stationary phase density relative to the wild type (dark blue). …”
-
1951
-
1952
Inhibition of TRPC3 decreases ATP- and OAG-induced Ca<sup>2+</sup> transients in striatal astrocytes.
Published 2014“…Prior treatment with Pyr3 for 30 minutes at 37°C decreased the Ca<sup>2+</sup> response to ATP, whereas only a modest additive effect was observed with Pyr3 in the presence of 10 µM MPP<sup>+</sup>. …”
-
1953
-
1954
-
1955
-
1956
-
1957
Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension.
Published 2012“…<i>(B)</i> When the antagonist is administrated twice, intraocular pressure remains low during 6 weeks (n = 10 each); the black arrow indicates the period of retinal and visual <i>in vivo</i> testing presented in <i>Fig. 6A,B</i>. <i>(C)</i> Dose-dependent effect of two administrations of CXCR3 antagonist on intraocular pressure as tested two weeks after the treatment (n = 5 each). * <i>P</i><0.05, ** <i>P</i><0.01. …”
-
1958
-
1959
-
1960